208 related articles for article (PubMed ID: 27167827)
1. Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.
Moore LS; de Boer E; Warram JM; Tucker MD; Carroll WR; Korb ML; Brandwein-Gensler MS; van Dam GM; Rosenthal EL
Cancer Med; 2016 Jul; 5(7):1526-34. PubMed ID: 27167827
[TBL] [Abstract][Full Text] [Related]
2. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
[TBL] [Abstract][Full Text] [Related]
3. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
[TBL] [Abstract][Full Text] [Related]
4. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
[TBL] [Abstract][Full Text] [Related]
7. Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
Hiroshima Y; Maawy A; Zhang Y; Guzman MG; Heim R; Makings L; Luiken GA; Kobayashi H; Tanaka K; Endo I; Hoffman RM; Bouvet M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1469-74. PubMed ID: 25893411
[TBL] [Abstract][Full Text] [Related]
8. Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.
Nakajima T; Sano K; Mitsunaga M; Choyke PL; Kobayashi H
Cancer Res; 2012 Sep; 72(18):4622-8. PubMed ID: 22800710
[TBL] [Abstract][Full Text] [Related]
9. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
[TBL] [Abstract][Full Text] [Related]
10. Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
Siddiqui MR; Railkar R; Sanford T; Crooks DR; Eckhaus MA; Haines D; Choyke PL; Kobayashi H; Agarwal PK
Sci Rep; 2019 Feb; 9(1):2084. PubMed ID: 30765854
[TBL] [Abstract][Full Text] [Related]
11. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.
Mitsunaga M; Nakajima T; Sano K; Kramer-Marek G; Choyke PL; Kobayashi H
BMC Cancer; 2012 Aug; 12():345. PubMed ID: 22873679
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines.
Peng W; de Bruijn HS; Farrell E; Sioud M; Mashayekhi V; Oliveira S; van Dam GM; Roodenburg JLN; Witjes MJH; Robinson DJ
Lasers Surg Med; 2018 Jul; 50(5):513-522. PubMed ID: 29777587
[TBL] [Abstract][Full Text] [Related]
13. Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model.
Nakajima T; Sano K; Choyke PL; Kobayashi H
Theranostics; 2013; 3(6):357-65. PubMed ID: 23781283
[TBL] [Abstract][Full Text] [Related]
14. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
[TBL] [Abstract][Full Text] [Related]
15. The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.
Polikarpov DM; Campbell DH; Lund ME; Lu Y; Lu Y; Wu J; Walsh BJ; Zvyagin AV; Gillatt DA
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102064. PubMed ID: 33069874
[TBL] [Abstract][Full Text] [Related]
16. Dynamic fluorescent imaging with indocyanine green for monitoring the therapeutic effects of photoimmunotherapy.
Ali T; Nakajima T; Sano K; Sato K; Choyke PL; Kobayashi H
Contrast Media Mol Imaging; 2014; 9(4):276-82. PubMed ID: 24706611
[TBL] [Abstract][Full Text] [Related]
17. Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
Inagaki FF; Wakiyama H; Furusawa A; Okada R; Kato T; Fujimura D; Okuyama S; Fukushima H; Takao S; Choyke PL; Kobayashi H
Biomed Pharmacother; 2023 Apr; 160():114390. PubMed ID: 36791566
[TBL] [Abstract][Full Text] [Related]
18. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).
Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723
[TBL] [Abstract][Full Text] [Related]
19. A standardized light-emitting diode device for photoimmunotherapy.
de Boer E; Warram JM; Hartmans E; Bremer PJ; Bijl B; Crane LM; Nagengast WB; Rosenthal EL; van Dam GM
J Nucl Med; 2014 Nov; 55(11):1893-8. PubMed ID: 25315245
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer.
Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M
Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]